PPARG and metabolic disease: By interacting with nuclear receptors like PPAR-γ, hydroxycitric acid influences adipogenesis, lipid storage, and inflammatory pathways, offering therapeutic potential for managing metabolic disorders (Arefhosseini et al., 2022; Verrelli et al., 2022).